Opportunity

Simpler Grants.gov #PAR-27-090

NIH R01 research grants for palliative care across the lifespan

Buyer

National Institutes of Health

Posted

October 14, 2026

Respond By

November 05, 2029

Identifier

PAR-27-090

NAICS

541720, 541715

The National Institutes of Health (NIH) seeks R01 research applications advancing palliative care for people with serious illnesses and their care partners across the lifespan. - Government buyer: National Institutes of Health (NIH); no specific institute, sub-agency, or office is identified. - Research focus: Palliative care access, use, and quality. - Eligible research approaches: Clinical trials at NIH Stage Model Stages II–V, or non-clinical-trial studies such as health services, methodological, natural experiment, and observational research. - Consortium participation: Award recipients will participate in the NIH-funded Advancing the Science of Palliative Care Across the Lifespan (ASCENT) Consortium. - Important limitation: Stage I clinical-trial research focused on intervention development, refinement, adaptation, or pilot testing is not appropriate; proposed interventions must already be developed and testable. - OEMs, vendors, products, and quantities: None are identified; this is a research grant opportunity rather than a product procurement.

Description

This Notice of Funding Opportunity invites R01 applications for research on palliative care across the lifespan for people with serious illnesses and/or their care partners, including research on access, use, and quality. Proposed work may include clinical trials in NIH Stage Model Stages II–V or non-clinical-trial research such as health services, methodological, natural experiment, and observational studies. Selected recipients will join the NIH-funded Advancing the Science of Palliative Care Across the Lifespan (ASCENT) Consortium. Applications proposing Stage I intervention development, refinement, adaptation, or pilot-testing clinical trial research are not appropriate; interventions must already be developed and testable.

View original listing